Thibaut Barbier

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Crystal Structure

Respiratory Syndrome Coronavirus

Molecular Docking

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Laurent Soulère, Thibaut Barbier, Yves Queneau
In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Main Protease among a PubChem Database of Avian Infectious Bronchitis Virus 3CLPro Inhibitors. Biomolecules 13 (6) (2023)
Thibaut Barbier, Oana Dumitrescu, Gérard Lina, Yves Queneau, Laurent Soulère
Importance of the 2,6-Difluorobenzamide Motif for FtsZ Allosteric Inhibition: Insights from Conformational Analysis, Molecular Docking and Structural Modifications. Molecules (Basel, Switzerland) 28 (5) (2023)
Thibaut Barbier, Oana Dumitrescu, Gérard Lina, Yves Queneau, Laurent Soulère
Importance of the 2,6-Difluorobenzamide Motif for FtsZ Allosteric Inhibition: Insights from Conformational Analysis, Molecular Docking and Structural Modifications. Molecules (Basel, Switzerland) 28 (5) (2023)
Thibaut Barbier, Oana Dumitrescu, Gérard Lina, Yves Queneau, Laurent Soulère
Importance of the 2,6-Difluorobenzamide Motif for FtsZ Allosteric Inhibition: Insights from Conformational Analysis, Molecular Docking and Structural Modifications. Molecules (Basel, Switzerland) 28 (5) (2023)
Laurent Soulère, Thibaut Barbier, Yves Queneau
In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Main Protease among a PubChem Database of Avian Infectious Bronchitis Virus 3CLPro Inhibitors. Biomolecules 13 (6) (2023)
Laurent Soulère, Thibaut Barbier, Yves Queneau
In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Main Protease among a PubChem Database of Avian Infectious Bronchitis Virus 3CLPro Inhibitors. Biomolecules 13 (6) (2023)
Thibaut Barbier, Cédric Badiou, Floriane Davy, Yves Queneau, Oana Dumitrescu, Gérard Lina, Laurent Soulère
Structural Variations in the Central Heterocyclic Scaffold of Tripartite 2,6-Difluorobenzamides: Influence on Their Antibacterial Activity against MDR Staphylococcus aureus . Molecules (Basel, Switzerland) 27 (19) (2022)